Homozygous pathogenic mutations in the PPARG (3p25.2) or LMNA (1q22) genes cause a form of generalized lipodystrophy, while heterozygous carriers manifest a form of familial partial lipodystrophy (FPLD) [52]. Here, LMNA is linked to familial partial lipodystrophy.